* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Elucidating the complete reaction cycle for membrane
Signal transduction wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Adenosine triphosphate wikipedia , lookup
Proteolysis wikipedia , lookup
NADH:ubiquinone oxidoreductase (H+-translocating) wikipedia , lookup
Ultrasensitivity wikipedia , lookup
G protein–coupled receptor wikipedia , lookup
Protein–protein interaction wikipedia , lookup
Magnesium in biology wikipedia , lookup
Biochemistry wikipedia , lookup
Western blot wikipedia , lookup
Oxidative phosphorylation wikipedia , lookup
Biosynthesis wikipedia , lookup
Photosynthetic reaction centre wikipedia , lookup
Evolution of metal ions in biological systems wikipedia , lookup
Citric acid cycle wikipedia , lookup
Catalytic triad wikipedia , lookup
Enzyme inhibitor wikipedia , lookup
Elucidating the complete reaction cycle for membrane-bound pyrophosphatases Craig Wilkinson, Nita Shah and Adrian Goldman Introduction Pyrophosphate (PPi) is abundant in cells as a by-product of cellular anabolic processes such as the hydrolysis of ATP. Membrane-bound pyrophosphatases (MPPases) are helical transmembrane enzymes that couple the hydrolysis of PPi to the pumping of protons (H+) and/or sodium ions (Na+) across a membrane, generating a chemical and electrical potential. This potential can be used to drive other cellular reactions such as ATP synthesis and the primary active transport of solutes. MPPases are found in bacteria, archaea, protozoans and plants, but not in mammals. Crucially, MPPases are found in numerous bacterial and protozoan parasites such as Plasmodium spp. (malaria), Toxoplasma gondii (toxoplasmosis), Trypanosoma spp. (trypanosomiasis), Leishmania spp. (leishmaniasis) and Clostridium spp. (infectious diarrhoea). In these organisms, MPPase is essential during stress such as lowenergy conditions, cold-shock and osmotic stress, and therefore has been validated as a drug target against several of these parasites. Our work has focused on obtaining threedimensional models of Thermotoga maritima Na+-pumping MPPase (TmPPase) and the Vigna radiata H+-pumping MPPase (VrPPase) during various stages of the reaction cycle in order to elucidate the reaction mechanism. Understanding the mechanism of MPPases is essential for exploiting this enzyme as a drug target, and atomic models of MPPase can be used for structure based drug design approaches. Results We have recently solved the strucutres of substrate analogue (IDP) and Na+ bound TmPPase, and single phosphate bound VrPPase. We integrated this knowledge with our previous structures of TmPPase in resting and product-bound states and VrPPase in an IDP-bound state to follow the structural changes in MPPases throuhgout the reaction cycle. These structures revealed MPPases are homodimeric, and each monomer has a novel 16 transmembrane-helical structure (Fig. 1). This integral-membrane protein consists of a IDP Mg2+ Cell inner-membrane Cytoplasm Na+ Figure 1. Structure of Thermotoga maritima MPPase (TmPPase). Dimeric TmPPase bound with the PPi 2+ + analogue IDP (orange), Mg (green) and Na (purple). One monomer of TmPPase has been coloured light blue, the other dark blue. The position of the lipid membrane is represented by a bilayer assembled using course grained MD simulations. The top of the enzyme (bound to PPi) is facing the cytoplasm whereas the bottom of the enzyme is facing the periplasm. Periplasm continuous active site with four distinct parts: the cytoplasmic facing hydrolytic centre, the coupling funnel, the ion gate, and the periplasmic facing exit channel (Fig. 1). By analysing the different MPPase strucutres, we have identified the major steps during the PPi cleavage and ion-pumping in the reaction cycle. When substrate binds and the loops on the cytoplasmic side close, the transported ion (Na+ or H+) binds to the ion-binding site at the ionic-gate, displacing a lysine (K16.50) from the gate (Fig. 2A). This is either driven by, or drives, the ‘downward’ movement of tranmembrane helix (TMH) 6. The downward motion of TMH 6 activates the enzyme by placing an aspartic acid (D6.43) into position, which (a) (b) Figure 2: Transitions in the coupling funnel of TmMPPase during the catalytic cycle. (a) TmMPPase in the substrate analogue-bound state, + revealing the position of bound Na (purple) coordinated by acidic residues (blue dashes). (b) Comparison of TmPPase in the resting state with no product or substrate bound (light blue) with a formed salt-bridge network (magenta dashes) against substrate + analogue and Na bound TmPPase (dark blue). This highlights the changes in the position of D6.43 and D16.39 between resting and substrate bound states. coordinates a water nucleophile in the coupling funnel (Fig. 2B). Concomitantly, there is a constriction of the active site cavity by the movement of the cytoplasmic ends of TMHs 5, 6, 11, 12, 15 and 16, and capping of the active site by the helix 5-6 loop. The hydrolysis of PPi then drives the enzyme into an occluded state, open neither to the cytoplasm nor the periplasm. We posit that ion-pumping requires a short-lived transition state in which the iongate and the exit channel open in sequence, which likely involves the ‘downward’ movement of TMH 12. There may be a second, loosely-bound state for the pumped ion on the periplasmic side of a glutamic acid residue (E6.53 in TmPPase); in such a state, K16.50 would swing back in to close the ionic gate from the cytoplasmic side. Only after these steps have occured can the active site reopen on cytoplasmic side, allowing the leaving group phosphate to diffuse away, and the enzyme to return to the resting state. Publications Saarenpää T.J., Jaakola V-P & Goldman A. (2015) Baculovirus mediated expression of GPCRs in insect cells. Methods Enzymol. 556:185-218. Rosti K., Goldman A. & Kajander T. (2015) Solution structure and biophysical characterization of the multifaceted signalling effector protein growth arrest specific-1. BMC Biochem. 16: 8. Bhattacharjee A., Reuter S., Trojnar E., Kolodziejczyk R., Seeberger H., Hyvarinen S., Uzonyi B., Szilagyi A., Prohaszka Z., Goldman A., Jozsi M., Jokiranta T.S. (2015) The major autoantibody epitope on Factor H in atypical Hemolytic Uremic Syndrome is structurally different from its homologous site in Factor H related protein 1 supporting a novel model for induction of autoimmunity in this disease. J. Biol. Chem. 10:9500-9510. Funding This work was funded by the BBSRC and the H2020 program: Nita Shah is a Marie Curie fellow. Collaborators University of Leeds: S. Harris, L. Jeuken and R. Tuma. External: J. Kellosalo, T. Kajander, Y-J. Sun, J. Yli-Kauhaluoma, H. Xhaard, S. Meri, R. Lahti.